Genetic Predictors of Responsiveness to Radiofrequency Denervation in Chronic Low Back Pain

NCT02383524 | Unknown

• 1 other identifier: 418120
• Study Type: observational
• Target: 70
• Locations: 1 country
• Sites: 1

Brief Summary

The Investigators have designed this exploratory study in patients suffering from zygapophysial joint mediated pain to investigate if a correlation exists between inter-individual genetic variability (genotype) with treatment response (phenotype). More specifically, the investigators aim to identify any form of correlation between a specific SNP of the BDNF gene (Val66Met) and the effectiveness and/or duration of radiofrequency facet joint neurotomy. The study population is patients suffering from chronic low back pain who have been scheduled for radiofrequency neurotomy following the diagnosis of facet joint mediated pain (using medial branch block test). The investigators will evaluate if a common variant of BDNF gene (Val66Met) can be directly correlated to a significant degree of pain relief following RF treatment, and whether the result of such a procedure can be predicted from a specific genetic profile.

Conditions

Chronic Low Back Pain

Outcome Measures

Primary Outcomes (1)

• Responder Rate

  Number of patients in each group who report 50% reduction in pain on the visual analogue scale 3 months after radiofrequency denervation for lumbar zygapophysial (facet) joint mediated pain

  3 months

Secondary Outcomes (1)

• Medication intake, Functional status, Ability to work and Quality of life

  3 months

Other Outcomes (1)

• Pre-specified Single Nucleotide Polymorphism (SNP) analysis

  3 months

Study Arms (1)

Chronic Low Back Pain (Lumbar Facet Joints Mediated Pain)

Procedure: Lumbar Radiofrequency Medial Branch Neurolysis

Interventions

Lumbar Radiofrequency Medial Branch Neurolysis PROCEDURE

Numerous studies have concluded that facet joint pain can be accurately diagnosed if a significant (but temporary) reduction in pain is achieved with a procedure called a Medial Branch Block (MBB). The clinician delivers a targeted injection of local anesthetic to the joint itself, or in close proximity to the medial branch of the posterior rami of the dorsal root. A significant decrease in pain confirms that the pain originates from the facet joint. If or when the pain returns after successful MBB treatment the patient may be considered for radiofrequency denervation (neurotomy) which selectively disrupts the joint's nerve supply and provides longer-term sustained relief

Chronic Low Back Pain (Lumbar Facet Joints Mediated Pain)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients suffering from chronic and debilitating low back pain with a diagnosis of lumbar zygapophysial joint mediated pain which has not been effectively treated with conservative pharmacological treatment or alternative non-invasive treatments

You may qualify if:

• Diagnosed with chronic low back pain which is unresponsive to conservative treatment (including suitable analgesics and physical therapy);
• Willing to provide consent
• Subject is capable of comprehending the patient information sheet and has the capacity to give their informed consent to all study procedures in English
• Be 18 years or older at the time of enrolment;
• Have specific low back pain that is aggravated by hyperextension and rotation of the spine, with or without hip, buttock or leg pain that does not follow a known dermatomal distribution
• Paraspinal Tenderness
• A "positive" response to a uni/bi-lateral MBB\* (a response is considered positive when a subject experiences at least 50% reduction in pain scores after the block, regardless of the duration of pain relief)

You may not qualify if:

• Patients who had had any previous back surgery
• Patients who had previous RF treatments for facet joints mediated pain
• Patients with another significant cause of low back pain (like spinal stenosis, disc herniation, spondylolisthesis, malignancy, infection or trauma);
• Radicular pain (pain with neuropathic characteristics following one or more nerve root distribution)
• Patients with bleeding complications or coagulopathy issues;
• Concurrent participation in other experimental trials;
• Known history of adverse reactions to local anesthetics;
• Pregnant or lactating women;
• Refusal to provide informed consent for blood banking
• Any other complication which in the view of the investigator may interfere with the study procedures or the measurement of the accurate study outcomes

Sponsors & Collaborators

• Guy's and St Thomas' NHS Foundation Trust: lead
• University of Parma: collaborator

Study Sites (1)

Guy's & St Thomas NHS Trust

London, SE1, United Kingdom

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples

Central Study Contacts

Stefano Palmisani, MD

CONTACT

+44 (0)2071883237; stefano.palmisani@gstt.nhs.uk

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 4, 2015
• First Posted: March 9, 2015
• Study Start: February 1, 2015
• Primary Completion: February 1, 2016
• Study Completion: February 1, 2017
• Last Updated: March 11, 2015

Record last verified: 2015-03

Locations

GB (1)